Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 182.68M | $ 163.28M | $ 175.00M | $ 172.68M | $ 132.27M |
Total Assets | $ 227.79M | $ 253.29M | $ 241.55M | $ 255.73M | $ 172.22M |
Total Debt | $ ― | $ 3.14M | $ ― | $ 4.36M | $ ― |
Net Debt | $ ― | $ -160.14M | $ ― | $ -168.32M | $ ― |
Total Liabilities | $ 86.47M | $ 97.04M | $ 94.72M | $ 104.29M | $ 57.79M |
Stockholders Equity | $ 141.32M | $ 156.25M | $ 146.84M | $ 151.44M | $ 114.43M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |